EPS8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.112410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.366800E-01
Normal-vs-Stage2
8.110400E-02
Normal-vs-Stage3
5.451000E-01
Normal-vs-Stage4
3.673800E-02
Stage1-vs-Stage2
4.412200E-01
Stage1-vs-Stage3
3.143200E-01
Stage1-vs-Stage4
1.302640E-01
Stage2-vs-Stage3
1.206190E-01
Stage2-vs-Stage4
2.792800E-01
Stage3-vs-Stage4
1.938280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.199590E-01
Normal-vs-AfricanAmerican
9.822400E-02
Normal-vs-Asian
2.797200E-01
Caucasian-vs-AfricanAmerican
4.455000E-01
Caucasian-vs-Asian
5.471400E-01
AfricanAmerican-vs-Asian
3.428800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.277610E-01
Normal-vs-Female
9.902300E-02
Male-vs-Female
5.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.054800E-01
Normal-vs-Age(41-60Yrs)
5.822200E-02
Normal-vs-Age(61-80Yrs)
1.581220E-01
Normal-vs-Age(81-100Yrs)
9.579900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.266000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.848200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.702800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.919850E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.365600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.795400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.072000E-02
Normal-vs-Daily Drinker
2.764800E-01
Normal-vs-Weekly Drinker
2.720000E-01
Normal-vs-Occasional Drinker
1.256380E-01
Normal-vs-Social Drinker
8.417700E-02
Non Drinker-vs-Daily Drinker
3.290200E-01
Non Drinker-vs-Weekly Drinker
7.026600E-01
Non Drinker-vs-Occasional Drinker
2.328200E-01
Non Drinker-vs-Social Drinker
7.108200E-01
Daily Drinker-vs-Weekly Drinker
7.110800E-01
Daily Drinker-vs-Occasional Drinker
7.238400E-02
Daily Drinker-vs-Social Drinker
2.722600E-01
Weekly Drinker-vs-Occasional Drinker
2.301600E-01
Weekly Drinker-vs-Social Drinker
5.659800E-01
Occasional Drinker-vs-Social Drinker
4.137800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.504600E-01
Normal-vs-Grade 2
3.141900E-02
Normal-vs-Grade 3
5.082500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.987860E-02
Grade 1-vs-Grade 3
5.800900E-04
Grade 1-vs-Grade 4
2.504600E-01
Grade 2-vs-Grade 3
4.616200E-02
Grade 2-vs-Grade 4
3.141900E-02
Grade 3-vs-Grade 4
5.082500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.816580E-01
Normal-vs-NonDiabetic
1.208360E-01
Diabetic-vs-NonDiabetic
1.460600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.527020E-01
Normal-vs-NoPancreatitis
1.402960E-01
Pancreatitis-vs-NoPancreatitis
7.329000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.691810E-01
Normal-vs-N1
8.369500E-02
N0-vs-N1
1.108440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.186000E-02
Normal-vs-TP53-NonMutant
2.511600E-01
TP53-Mutant-vs-TP53-NonMutant
1.778500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
